IDEXX Laboratories Inc. (IDXX)

194.61
0.76 0.39
NASDAQ : Health Technology
Prev Close 193.85
Open 193.69
Day Low/High 191.54 / 195.25
52 Wk Low/High 146.09 / 207.14
Volume 301.76K
Avg Volume 529.90K
Exchange NASDAQ
Shares Outstanding 87.06M
Market Cap 17.25B
EPS 3.00
P/E Ratio 67.22
Div & Yield N.A. (N.A)

Latest News

Behind the Selloff: Cramer's 'Mad Money' Recap (Friday 4/6/18)

Behind the Selloff: Cramer's 'Mad Money' Recap (Friday 4/6/18)

This market is deceptive and you need to recognize your sense of timing is not infallible. So, adjust your scales and get ready for next week, says Jim Cramer.

IDXX: Insiders vs. Shorts

IDXX: Insiders vs. Shorts

The most recent short interest data was recently released for the 02/28/2018 settlement date, and Idexx Laboratories, Inc. is the #162 most shorted of the S&P 500 components, based on 3.52 "days to cover." There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

STMicroelectronics, PetMed Express: 'Mad Money' Lightning Round

STMicroelectronics, PetMed Express: 'Mad Money' Lightning Round

Jim Cramer focuses on STMicroelectronics, PetMed Express, Lumentum Holdings, and Allergan.

Big Earnings Week Ahead: Cramer's 'Mad Money' Recap (Monday 2/26/18)

Big Earnings Week Ahead: Cramer's 'Mad Money' Recap (Monday 2/26/18)

Jim Cramer is keeping a close eye on retail earnings this week, along with testimony from new Fed Chair Jerome Powell.

General Mills Buys Blue Buffalo for $8 Billion -- Who's Next?

General Mills Buys Blue Buffalo for $8 Billion -- Who's Next?

General Mills is buying Blue Buffalo for $8 billion. It's not the first deal in the pet space and it won't be the last.

Cramer: These Stocks Are on a Mission Right Now

Cramer: These Stocks Are on a Mission Right Now

They are objects that once in motion, stay in motion.

Don't Fall for the Downward Bias: Cramer's 'Mad Money' Recap (Thursday, 2/1/18)

Don't Fall for the Downward Bias: Cramer's 'Mad Money' Recap (Thursday, 2/1/18)

Jim Cramer says being a realistic investor doesn't mean being negative, especially when solid reality supports optimism.

Cramer: What Stocks Are On a Mission Right Now?

Cramer: What Stocks Are On a Mission Right Now?

They are objects that once in motion, stay in motion.

Idexx Laboratories Becomes #47 Most Shorted Nasdaq 100 Component, Replacing Xilinx

Idexx Laboratories Becomes #47 Most Shorted Nasdaq 100 Component, Replacing Xilinx

The most recent short interest data has been released for the 12/29/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

IDEXX To Introduce Applied BioCode's Innovative Multiplex Technology Across Global Reference Laboratory Network

IDEXX To Introduce Applied BioCode's Innovative Multiplex Technology Across Global Reference Laboratory Network

IDEXX Laboratories, Inc. (NASDAQ: IDXX) and Applied BioCode (6598:Taipei) today announced that they have entered into an exclusive global agreement to bring Applied BioCode's digital multiplex platform to IDEXX Reference...

Meet TheStreet's Pets! They May Be Expensive -- But We Love Them!

Meet TheStreet's Pets! They May Be Expensive -- But We Love Them!

Meet TheStreet's favorite pets! We love them, but let's be real, they get expensive too. But even after all we spend year-round -- and wait until you hear how much that is -- you know we're still going to make sure there are presents under the tree. Watch our video now!

Cramer: Brand Loyalty Between Generations Is Dying

Cramer: Brand Loyalty Between Generations Is Dying

There's a reason to keep coming back to Apple, Facebook, Amazon, Alphabet and Netflix.

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

Lose the cynicism or you might miss the move. Jim Cramer outlines the reasons for these gains and why investors need to watch them.

McDonald's, Ultra Clean Holdings, Aetna: 'Mad Money' Lightning Round

McDonald's, Ultra Clean Holdings, Aetna: 'Mad Money' Lightning Round

Jim Cramer is bullish on McDonald's, Ultra Clean Holdings, Aetna, Baozun and more.

Breaking Down This Downturn: Cramer's 'Mad Money' Recap (Tuesday, 11/14/17)

Breaking Down This Downturn: Cramer's 'Mad Money' Recap (Tuesday, 11/14/17)

Jim Cramer analyzes the reasons investors should be worried, and more important, why this is the pullback that presents buying opportunities.

The Humanization of Pets Has Changed the World -- Here's the Best Stock Pick

The Humanization of Pets Has Changed the World -- Here's the Best Stock Pick

Idexx Labs is changing the game and capitalizing on the deep love and affection we share for those furry, four-legged friends.

The Humanization of Pets Has Changed the Industry -- Here's the Best Stock Pick

The Humanization of Pets Has Changed the Industry -- Here's the Best Stock Pick

Idexx Labs is changing the game and capitalizing on the deep love and affection we share for those furry, four-legged friends.

12 Stocks This Top Research Firm Wants You to Buy Now

12 Stocks This Top Research Firm Wants You to Buy Now

These are the 12 best investment selections from Fundstrat that may provide investors with 'timely' long-term potential.

Arconic, Idexx Laboratories, AbbVie: 'Mad Money' Lightning Round

Arconic, Idexx Laboratories, AbbVie: 'Mad Money' Lightning Round

Jim Cramer is bullish on Arconic, Idexx Laboratories, AbbVie. He's bearish on Fitbit, Qualcomm and Walgreens.

Don't Get Shaken Out of Good Stocks: Cramer's 'Mad Money' Recap (Wed 9/13/17)

Don't Get Shaken Out of Good Stocks: Cramer's 'Mad Money' Recap (Wed 9/13/17)

Don't be distracted and start buying high and selling low, says Jim Cramer. A good example? Don't trade Apple, own it.

Idexx Laboratories Becomes #44 Most Shorted Nasdaq 100 Component, Replacing Amgen

Idexx Laboratories Becomes #44 Most Shorted Nasdaq 100 Component, Replacing Amgen

The most recent short interest data has been released for the 08/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

TheStreet Quant Rating: B- (Buy)